Revance Therapeutics Inc (RVNC)

[vinmantoo]

There are those that would tell you the company is right where it should be at this stage, but the market has clearly spoken. It's going to be a much longer, and much more expensive slog than I ever realized. To me 2nd quarter #'s were key, and it's obvious to me excitement in marketplace is lacking.

I tempered my expectations so I am not disappointed in the sales in cosmetics so far. Keep in mind that RVNC said the launch of Daxxify was more successful that other Botox entrants have been. I never focused on the 1st or 2nd quarter sales. Perhaps Q3 or even Q4 sales will begin to give us a good feel for the sales uptake. You know ABBV is worried as they commented about Daxxify and they lied about its uptake by claiming it wasn't selling as well as other entrants. ABBV is worried but I am not.